Provectus Biopharmaceuticals Inc

General ticker "PVCT" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $52.5M

Provectus Biopharmaceuticals Inc does not follow the US Stock Market performance with the rate: -14.3%.

Estimated limits based on current volatility of 3.9%: low 0.12$, high 0.13$

Factors to consider:

  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.05$, 0.14$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.04$, 0.11$]

Financial Metrics affecting the PVCT estimates:

  • Negative: Non-GAAP EPS, $ of -0.01 <= 0.10
  • Negative: Operating profit margin, % of -83.88 <= 1.03
  • Negative: Operating cash flow per share per price, % of -5.06 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31

Similar symbols

Short-term PVCT quotes

Long-term PVCT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.99MM $0.56MM
Operating Expenses $4.67MM $4.42MM $3.46MM
Operating Income $-4.67MM $-3.43MM $-2.90MM
Non-Operating Income $-0.87MM $-0.13MM $-0.20MM
Interest Expense $0.96MM $0.16MM $0.22MM
R&D Expense $2.61MM $2.39MM $1.75MM
Income(Loss) $-5.54MM $-3.55MM $-3.10MM
Taxes $0.96MM $-0.00MM $0.00MM
Profit(Loss) $-6.50MM $-3.55MM $-3.10MM
Stockholders Equity $-4.19MM $-6.23MM $-7.59MM
Inventory $2.42MM $1.41MM $0.00MM
Assets $3.51MM $2.04MM $1.45MM
Operating Cash Flow $-1.01MM $-3.04MM $-2.57MM
Capital expenditure $0.00MM $0.00MM $0.00MM
Investing Cash Flow $-0.00MM $-0.00MM $0.00MM
Financing Cash Flow $4.02MM $1.37MM $2.19MM
Earnings Per Share* $-0.02 $-0.01 $-0.01

* EPS are Split Adjusted, recent splits may be reflected with a delay.